Weifang Yaxing Chemical Co., Ltd. (SHA:600319)
China · Delayed Price · Currency is CNY 7.99
-0.05 (-0.62%)
At close: Feb 13, 2026
Weifang Yaxing Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 872.96 | 889.63 | 820.43 | 841.58 | 191.57 | 45.13 |
Other Revenue | 20.78 | 20.78 | 4.42 | 5.07 | 1.14 | 4.17 |
| 893.75 | 910.42 | 824.85 | 846.65 | 192.7 | 49.29 | |
Revenue Growth (YoY) | 4.12% | 10.37% | -2.57% | 339.36% | 290.93% | -97.02% |
Cost of Revenue | 911.93 | 900.74 | 809.71 | 725.32 | 193.66 | 44.57 |
Gross Profit | -18.18 | 9.68 | 15.14 | 121.33 | -0.96 | 4.72 |
Selling, General & Admin | 70.38 | 67.18 | 65.3 | 56.31 | 49.87 | 39.12 |
Research & Development | 10 | 9.67 | 8.6 | 8.32 | 5 | 2.26 |
Other Operating Expenses | 9.22 | 7.74 | 6.84 | 2.7 | 5.26 | 2.62 |
Operating Expenses | 94.87 | 91.77 | 81.97 | 67.69 | 57.29 | 35.86 |
Operating Income | -113.05 | -82.09 | -66.83 | 53.64 | -58.25 | -31.14 |
Interest Expense | -76.54 | -66.11 | -51.44 | -46.79 | -53.77 | -0 |
Interest & Investment Income | 0.88 | 0.42 | 2.86 | 2.42 | 4.26 | 8 |
Currency Exchange Gain (Loss) | -1.94 | -1.94 | -1.03 | 0.14 | -0.01 | -0.66 |
Other Non Operating Income (Expenses) | -13.94 | -7.08 | 5.49 | 15.9 | 287.87 | -1.91 |
EBT Excluding Unusual Items | -204.58 | -156.8 | -110.95 | 25.31 | 180.1 | -25.72 |
Gain (Loss) on Sale of Investments | -3.62 | -2.4 | - | -0.1 | - | - |
Gain (Loss) on Sale of Assets | -0.27 | 0.03 | 0.11 | 93.45 | 0.09 | -0.01 |
Asset Writedown | 2.96 | - | - | - | - | - |
Other Unusual Items | 61.87 | 60.85 | 117.52 | 0.45 | 12.86 | 0.05 |
Pretax Income | -143.65 | -98.33 | 6.68 | 119.11 | 193.05 | -25.67 |
Income Tax Expense | 0.41 | 0.42 | 0.41 | 10.27 | 0.02 | - |
Earnings From Continuing Operations | -144.06 | -98.75 | 6.28 | 108.84 | 193.03 | -25.67 |
Minority Interest in Earnings | 1.41 | 1.72 | 0.09 | - | - | - |
Net Income | -142.65 | -97.03 | 6.36 | 108.84 | 193.03 | -25.67 |
Net Income to Common | -142.65 | -97.03 | 6.36 | 108.84 | 193.03 | -25.67 |
Net Income Growth | - | - | -94.15% | -43.61% | - | - |
Shares Outstanding (Basic) | 385 | 388 | 318 | 351 | 316 | 321 |
Shares Outstanding (Diluted) | 385 | 388 | 318 | 351 | 316 | 321 |
Shares Change (YoY) | 20.88% | 21.97% | -9.37% | 10.96% | -1.40% | -1.14% |
EPS (Basic) | -0.37 | -0.25 | 0.02 | 0.31 | 0.61 | -0.08 |
EPS (Diluted) | -0.37 | -0.25 | 0.02 | 0.31 | 0.61 | -0.08 |
EPS Growth | - | - | -93.55% | -49.18% | - | - |
Free Cash Flow | -372.18 | -49.89 | -416.28 | -0.29 | -306.17 | -338.98 |
Free Cash Flow Per Share | -0.97 | -0.13 | -1.31 | -0.00 | -0.97 | -1.06 |
Gross Margin | -2.03% | 1.06% | 1.84% | 14.33% | -0.50% | 9.58% |
Operating Margin | -12.65% | -9.02% | -8.10% | 6.34% | -30.23% | -63.18% |
Profit Margin | -15.96% | -10.66% | 0.77% | 12.86% | 100.17% | -52.09% |
Free Cash Flow Margin | -41.64% | -5.48% | -50.47% | -0.03% | -158.88% | -687.67% |
EBITDA | -16.28 | 0.71 | -2.64 | 106.03 | -36.59 | -25.6 |
EBITDA Margin | -1.82% | 0.08% | -0.32% | 12.52% | -18.99% | -51.93% |
D&A For EBITDA | 96.77 | 82.8 | 64.19 | 52.39 | 21.67 | 5.54 |
EBIT | -113.05 | -82.09 | -66.83 | 53.64 | -58.25 | -31.14 |
EBIT Margin | -12.65% | -9.02% | -8.10% | 6.33% | -30.23% | -63.18% |
Effective Tax Rate | - | - | 6.08% | 8.62% | 0.01% | - |
Revenue as Reported | 893.75 | 910.42 | 824.85 | 846.65 | 192.7 | 49.29 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.